CA-WORLDLY
Worldly, the leading supply chain sustainability data and insights platform for the consumer goods and apparel industries, today announced the launch of Facility Data Manager (FDM) to help businesses more effectively track ongoing progress towards their decarbonization targets and make decisions that drive environmental improvements faster. As sustainability regulations such as the Corporate Sustainability Reporting Directive (CSRD) emerge globally, FDM helps brands prepare for environmental reporting requirements by providing timely primary data that aligns with regulatory frameworks.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240521428850/en/
As sustainability regulations such as the Corporate Sustainability Reporting Directive (CSRD) emerge globally, Facility Data Manager helps brands prepare for environmental reporting requirements by providing timely primary data that aligns with regulatory frameworks. (Graphic: Business Wire)
Aligned with Cascale’s industry standard Higg Facility Environmental Module (FEM) — the most comprehensive assessment for environmental performance in the consumer goods industry — Worldly’s new Facility Data Manager enables manufacturing facilities to regularly share key impact data with their brand and retail partners. Brands can access quantitative data on energy, water, waste and other impacts submitted by dozens to thousands of manufacturing facilities, as frequently as monthly. With FDM, brands can see the waste, water and emissions they are uniquely responsible for within a single factory. This addresses a critical industry need for more timely, standardized, high-quality primary data and insights for assessing ongoing risks and opportunities for supply chain improvements and reporting sustainability progress.
"We are pleased to introduce Facility Data Manager as a transformative addition to Worldly’s sustainability solutions," says Scott Raskin, CEO of Worldly. “At Worldly, our goal is to help companies make clear, credible progress against their environmental and labor targets while helping them prepare and comply with important evolving regulatory requirements. This requires more actionable data and deeper collaboration between manufacturers and brands. I’m excited about the improved insights and transparency into performance, targets and progress that Facility Data Manager provides, and the new level of partnership that it enables as companies look to accelerate impact across the supply chain.”
Manufacturing facilities that complete the annual Higg FEM assessment can automatically import monthly data from FDM into Higg FEM, reducing reporting time and avoiding redundancy of work. Additionally, within FDM, facilities can track their own sustainability targets and share progress with their brand and retailer partners, enabling a new level of collaboration and transparency across the complex global supply chain.
"Strong communication with our brand partners is essential to our business,” Cecilia Chan, Chief Commercial Officer of Legend Swimwear Factory Limited, said. “Sustainability innovations like this from Worldly deepen our collaboration with brands and make it much easier for us to not only help them meet their environmental targets, but ours as well."
Facility Data Manager has been developed in alignment with the Higg FEM tool established by Cascale (formerly Sustainable Apparel Coalition) in 2011. As the most widely used standardized measurement framework within the apparel and footwear industry, the Higg Index suite of tools is available exclusively on the Worldly platform and used by 350+ brands and 40,000 facilities around the world for measuring environmental and social impact. Cascale will soon begin to engage its members through a governance process to support FDM’s adoption into the Higg Index.
“We welcome the additional data insights and synergistic opportunities provided by Worldly's Facility Data Manager," said Colin Browne, CEO of Cascale, the global nonprofit alliance empowering collaboration to drive equitable and restorative business practices in the consumer goods industry. "FDM integrates seamlessly with Cascale's Higg Facility Environmental Module to provide a clear and transparent picture of environmental impacts and help our members improve sustainability and align with relevant industry standards. It’s exactly what our industry needs to catalyze impact at scale.”
For more information about Facility Data Manager and Worldly's solutions, please visit worldly.io.
About Worldly
Worldly is the planet’s most comprehensive supply chain sustainability data and insights platform, trusted by 40,000+ major brands, retailers and manufacturers in fashion, outdoor, home goods, toys and more. Worldly uniquely collects high-resolution primary data specific to companies’ value chains, operations and products, providing insight into true impacts across carbon, water, chemistry and labor. Featuring the most comprehensive source of ESG data for global manufacturers and the largest library of materials and product impacts, Worldly empowers businesses to scale responsibility into their global operations, faster and more accurately. Hosting, connecting with, and supporting the leading industry solutions and methodologies including ZDHC, Bluesign and the Higg Index – the most widely-adopted measure of sustainability in the consumer goods industry – Worldly delivers the insights businesses need to reduce their impact, comply with emerging regulatory and financial disclosure requirements and meet the expectations of a new generation of customers. www.worldly.io
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240521428850/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Sonrotoclax Data at ASH 2025 Confirm Foundational Potential Across B-cell Malignancies8.12.2025 00:00:00 CET | Press release
Novel BCL2 inhibitor sonrotoclax monotherapy demonstrates deep and durable clinical responses in R/R MCL and R/R CLLSonrotoclax in combination with BRUKINSA demonstrated rapid MRD negativity in treatment-naive CLL, regardless of high-risk features BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new data on sonrotoclax, a next-generation investigational BCL2 inhibitor, demonstrating meaningful clinical benefit as monotherapy and in combination across B-cell malignancies. These data were featured at the 67th American Society of Hematology (ASH) Annual Meeting & Exposition in Orlando, Florida. The five presentations highlight durable responses in heavily pretreated patients with relapsed/refractory (R/R) mantle cell lymphoma (MCL) and additional studies showing deep, rapid, and sustained undetectable minimal residual disease (uMRD) rates with sonrotoclax-based combinations in patients with treatment-naive chronic lymphocytic leukemi
Andersen Consulting tilføjer samarbejdsfirmaet Codezilla7.12.2025 21:19:00 CET | Pressemeddelelse
Andersen Consulting styrker sine kompetencer inden for digital transformation gennem en samarbejdsaftale med Codezilla, et firma med hovedsæde i Rumænien, der udvikler specialtilpasset software. Codezilla specialiserer sig i at udvikle skræddersyede softwareprodukter, der løser forretningsmæssige udfordringer gennem en tværfaglig tilgang, som kombinerer softwareudvikling med dybdegående marketingekspertise. Med over 30 år på markedet fungerer firmaet som implementerings- og digital konsulentressource for reklamebureauer, samtidig med at de arbejder med en bred kundebase, herunder virksomheder inden for sundhedssektoren og medicinsk udstyr. Codezillas interne teams strækker sig over teknik, design og strategi og leverer omnichannel-løsninger til både regionale og globale kunder. "Vi tror på, at fantastisk software er resultatet af solid ingeniørkunst og disciplineret eksekvering," udtaler Sebastian Doroftei, administrerende direktør for Codezilla. "Vores samarbejde med Andersen Consulti
Hemato-Oncology Trials: AOP Health Presents New Results at Top Congress ASH7.12.2025 17:00:00 CET | Press release
AOP Health continues to advance its clinical research program in myeloproliferative neoplasms, a special group of rare blood cancers. The company, specialized in rare diseases, presented the results of two scientific investigations at the 67th American Society of Hematology Association (ASH) Annual Meeting 2025 held in Orlando, FL, USA. The results provide new insights in treatment strategies. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251207587915/en/ Dr. Martin Steinhart, CEO AOP Health; Photo credit: AOP Health/Studio Koekart ROP-ET and BESREMI PASS One of the clinical studies, ROP-ET, examined the use of ropeginterferon alfa-2b in people with essential thrombocythemia (ET), a disease in which the body produces too many platelets. The trial, a prospective, multicenter, single-arm phase III study, investigated the safety and efficacy of ropeginterferon alfa-2b in ET patients unable to receive available cytoreductive th
CoMotion GLOBAL 2025 Launches in Riyadh: Global Mobility Leaders Unite in Saudi Capital to Chart Urban Future7.12.2025 13:00:00 CET | Press release
Summit debuts Mayors in Motion initiative and CoMotion Urban Visionary Distinction as Riyadh showcases its rise as global mobility testbed Riyadh is rapidly becoming one of the world's most ambitious urban mobility laboratories, where next-generation technologies move from blueprint to real-world deployment on city streets at unprecedented scale. CoMotion GLOBAL 2025, the world's most influential gathering of urban mobility leaders, opens today in Riyadh for a three-day summit bringing together innovators from Africa, Asia, Europe, the Americas, and the Middle East. Running December 7-9, the event will explore how electrification, autonomy, AI-enabled transport, and giga-project urbanism are reshaping cities worldwide. The summit will spotlight everything from high-performance EVs and breakthrough autonomous fleets to emerging-market transport solutions and new mobility models, demonstrating how the Kingdom is opening new pathways for global mobility leadership. Strategic Partnerships
Deciphera Announces Oral Presentation of Positive Topline Results from Phase 2a Study of Sapablursen in Polycythemia Vera at the 67th American Society of Hematology (ASH) Annual Meeting6.12.2025 15:30:00 CET | Press release
Results from Phase 2a IMPRSSION study demonstrate sapablursen significantly reduced phlebotomy rate, controlled hematocrit and increased serum hepcidin Sapablursen was generally safe and well tolerated Results support further development of sapablursen in a Phase 3 study Deciphera Pharmaceuticals, a member of Ono Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President and COO: Toichi Takino; “Ono”), today announced the oral presentation of positive results from the Phase 2a IMPRSSION study of sapablursen in patients with polycythemia vera (PV) at the 67th American Society of Hematology (ASH) Annual Meeting, taking place December 6-9, 2025, in Orlando, FL. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251206361611/en/ The results were presented by Ionis Pharmaceuticals, who discovered and developed sapablursen and conducted the IMPRSSION study. In March 2025, Ionis and Ono entered into a license agreement in which On
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
